Xu Wang

1PUBLICATIONS

8CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Mar 01, 2023

Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4- and PD-1-targeted immunotherapy.

Mingyue Liu, Xu Wang, Xuexiang Du

Pageof 1

Frequent Collaborators

1 joint publications

Mingyue Liu

1 joint publications

Xuexiang Du

1 joint publications

Yan Zhang

1 joint publications

Peng Zhang

1 joint publications

Musleh M Muthana

1 joint publications

Lishan Su

1 joint publications

Yang Liu

1 joint publications

Pan Zheng

Frequent Collaborators

1 joint publications

Mingyue Liu

1 joint publications

Xuexiang Du

1 joint publications

Yan Zhang

1 joint publications

Peng Zhang